Given the importance of EGFR activity in lung cancer, we confirmed the causal nature of PTPRH loss on EGFR activity through CRISPR mediated knockout of PPTPRH in a NSCLC line by observing increased pEGFR and pAKT. This evidence concerns the gene EGFR and non-small cell lung carcinoma.